View ERCC3 gene homepage

General information
Gene symbol ERCC3
Gene name excision repair cross-complementing rodent repair deficiency, complementation group 3
Chromosome 2
Chromosomal band q21
Imprinted Unknown
Genomic reference NG_007454.1
Transcript reference NM_000122.1
Associated with diseases ID, TTD, TTD-2, XPB
Citation reference(s) -
Curators (1) LOVD-team, but with Curator vacancy
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created May 03, 2013

Links to other resources
HGNC 3435
Entrez Gene 2071
PubMed articles ERCC3
OMIM - Gene 133510
OMIM - Diseases TTD-2 (trichothiodystrophy, type 2, photosentitive (TTD-2))
XPB (xeroderma pigmentosum, complementation group B (XPB))

Active transcripts




NCBI ID     

NCBI Protein ID     

00007207 2 excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) NM_000122.1 NP_000113.1 0

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2013-2017. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.